Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,235.19
(
-1.04%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 51
Posts 5537
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: mcbio post# 82218

Tuesday, 08/11/2009 11:51:14 PM

Tuesday, August 11, 2009 11:51:14 PM

Post# of 257580
"However, the company did say that the primary focus of this new class of compounds is on "issues of resistance and overall potency." "

isn't the rationale of any new class of antiviral related to potency and/or resistance?

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today